Skip to main content
NCBI home page
British Medical Journal logoLink to British Medical Journal
. 1979 Oct 20;2(6196):964–966. doi: 10.1136/bmj.2.6196.964

Haemostatic variables associated with diabetes and its complications.

J H Fuller, H Keen, R J Jarrett, T Omer, T W Meade, R Chakrabarti, W R North, Y Stirling
PMCID: PMC1596588  PMID: 509177

Abstract

To study the possible role of an "increased thrombotic tendency" in the vascular complications of diabetes several tests of haemostatic function were carried out on 91 men and 63 women with diabetes aged 35-54 years and the results compared with findings in 686 men and 393 women of the same age in the Northwick Park Heart Study. Mean values for factors VII and X, fibrinogen, and platelet adhesiveness were higher in the diabetics, but mean fibrinolytic activity and whole blood platelet counts were lower. Antithrombin III values were also higher in the diabetics, which may have constituted a protective response to other changes favouring the onset of vascular disease. Diabetics with retinopathy had higher factor VII and antithrombin III values, and those with proteinuria had higher values for factor VII, fibrinogen, and platelet adhesiveness than those without these complications. These findings suggest a potentially important association between a thrombogenic tendency and vascular disease in diabetes. Nevertheless, prospective data are needed to clarify whether the haemostatic abnormalities precede the onset of clinically manifest vascular complications or are a consequence of them.

Full text

PDF
964

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Almér L. O., Pandolfi M., Nilsson I. M. Diabetic retinopathy and the fibrinolytic system. Diabetes. 1975 Jun;24(6):529–534. [PubMed] [Google Scholar]
  2. Bern M. M. Platelet functions in diabetes mellitus. Diabetes. 1978 Mar;27(3):342–350. doi: 10.2337/diab.27.3.342. [DOI] [PubMed] [Google Scholar]
  3. Bogie W., George J., Crane C. W. Letter: Fibrinolytic activity in treatment of diabetes. Lancet. 1976 Aug 7;2(7980):312–312. doi: 10.1016/s0140-6736(76)90762-5. [DOI] [PubMed] [Google Scholar]
  4. Colwell J. A., Halushka P. V., Sarji K. E., Sagal J. Rationale for antiplatelet agents in diabetic vascular disease. Adv Exp Med Biol. 1978;102:243–254. doi: 10.1007/978-1-4757-1217-9_16. [DOI] [PubMed] [Google Scholar]
  5. EGEBERG O. THE BLOOD COAGULABILITY IN DIABETIC PATIENTS. Scand J Clin Lab Invest. 1963;15:533–538. [PubMed] [Google Scholar]
  6. FEARNLEY G. R., CHAKRABARTI R., AVIS P. R. Blood fibrinolytic activity in diabetes mellitus and its bearing on ischaemic heart disease and obesity. Br Med J. 1963 Apr 6;1(5335):921–923. doi: 10.1136/bmj.1.5335.921. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Ferguson J. C., Mackay N., Philip J. A., Sumner D. J. Determination of platelet and fibrinogen half-life with [75Se]selenomethionine: studies in normal and in diabetic subjects. Clin Sci Mol Med. 1975 Aug;49(2):115–120. doi: 10.1042/cs0490115. [DOI] [PubMed] [Google Scholar]
  8. Heath H., Brigden W. D., Canever J. V., Pollock J., Hunter P. R., Kelsey J., Bloom A. Platelet adhesiveness and aggregation in relation to diabetic retinopathy. Diabetologia. 1971 Oct;7(5):308–315. doi: 10.1007/BF01219463. [DOI] [PubMed] [Google Scholar]
  9. Hellem A. J. Adenosinediphosphate induced platelet adhesiveness in diabetes mellitus with complications. Acta Med Scand. 1971 Oct;190(4):291–295. doi: 10.1111/j.0954-6820.1971.tb07433.x. [DOI] [PubMed] [Google Scholar]
  10. Mayne E. E., Bridges J. M., Weaver J. A. Platelet adhesiveness, plasma fibrinogen and factor 8 levels in diabetes mellitus. Diabetologia. 1970 Aug;6(4):436–440. doi: 10.1007/BF01212078. [DOI] [PubMed] [Google Scholar]
  11. McMillan D. E. Deterioration of the microcirculation in diabetes. Diabetes. 1975 Oct;24(10):944–957. doi: 10.2337/diab.24.10.944. [DOI] [PubMed] [Google Scholar]
  12. Meade T. W., Haines A. P., North W. R., Chakrabarti R., Howarth D. J., Stirling Y. Haemostatic, lipid, and blood-pressure profiles of women on oral contraceptives containing 50 microgram or 30 microgram oestrogen. Lancet. 1977 Nov 5;2(8045):948–951. doi: 10.1016/s0140-6736(77)90888-1. [DOI] [PubMed] [Google Scholar]
  13. Meade T. W., North W. R., Chakrabarti R., Haines A. P., Stirling Y. Population-based distributions of haemostatic variables. Br Med Bull. 1977 Sep;33(3):283–288. doi: 10.1093/oxfordjournals.bmb.a071448. [DOI] [PubMed] [Google Scholar]
  14. Mustard J. F., Packham M. A., Kinlough-Rathbone R. L. Platelets and thrombosis in the development of atherosclerosis and its complications. Adv Exp Med Biol. 1978;102:7–30. doi: 10.1007/978-1-4757-1217-9_2. [DOI] [PubMed] [Google Scholar]
  15. O'Malley C. B., Ward J. D., Timperley W. R., Porter N. R., Preston F. E. Platelet abnormalities in diabetic peripheral neuropathy. Lancet. 1975 Dec 27;2(7948):1274–1276. doi: 10.1016/s0140-6736(75)90610-8. [DOI] [PubMed] [Google Scholar]
  16. Valdorf-Hansen F. Thrombocytes and coagulability in diabetics. Dan Med Bull. 1967 Sep;14(9):244–248. [PubMed] [Google Scholar]
  17. Yue R. H., Gertler M. M., Starr T., Koutrouby R. Alteration of plasma antithrombin III levels in ischemic heart disease. Thromb Haemost. 1976 Jun 30;35(3):598–606. [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES